About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
American Journal of Cardiovascular Drugs
›
Top Articles
American Journal of Cardiovascular Drugs
Pharmacology
4
(top 4%)
Impact Factor
4.4
(top 4%)
extended IF
51
(top 8%)
H-Index
695
authors
1.1K
papers
15.5K
citations
2.8K
citing journals
11.6K
citing authors
Most Cited Articles of American Journal of Cardiovascular Drugs
Title
Year
Citations
Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism
2008
456
Endogenous and exogenous cardiac glycosides and their mechanisms of action
2007
158
Drug-drug interaction studies of cardiovascular drugs involving P-glycoprotein, an efflux transporter, on the pharmacokinetics of edoxaban, an oral factor Xa inhibitor
2013
149
Interactions between grapefruit juice and cardiovascular drugs
2004
144
Thiazolidinediones and risk of heart failure in patients with or at high risk of type 2 diabetes mellitus: a meta-analysis and meta-regression analysis of placebo-controlled randomized clinical trials
2011
128
Cancer of the heart: epidemiology and management of primary tumors and metastases
2003
118
The cardioprotection of the insulin-mediated PI3K/Akt/mTOR signaling pathway
2014
117
Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome
2005
117
Effect of activated charcoal on apixaban pharmacokinetics in healthy subjects
2014
111
The role of the platelet in the pathogenesis of atherothrombosis
2005
103
Use of 24-hour ambulatory blood pressure monitoring to assess antihypertensive efficacy: a comparison of olmesartan medoxomil, losartan potassium, valsartan, and irbesartan
2005
101
The role of paraoxonase 1 activity in cardiovascular disease: potential for therapeutic intervention
2004
100
Current Overview on Hypercoagulability in COVID-19
2020
96
Icosapent ethyl, a pure ethyl ester of eicosapentaenoic acid: effects on circulating markers of inflammation from the MARINE and ANCHOR studies
2013
95
Cocaine Cardiotoxicity
2009
94
Bacterial pericarditis: diagnosis and management
2005
88
Management of Statin Intolerance in 2018: Still More Questions Than Answers
2018
86
Testosterone and atherosclerosis in aging men: purported association and clinical implications
2005
86
Cilostazol: a review of its use in intermittent claudication
2003
84
Calcium intake and risk of cardiovascular disease: a review of prospective studies and randomized clinical trials
2012
80
Coadministration of dabigatran etexilate and atorvastatin: assessment of potential impact on pharmacokinetics and pharmacodynamics
2009
77
Dyslipidemia in visceral obesity: mechanisms, implications, and therapy
2004
77
Compliance with antihypertensive therapy in the elderly: a comparison of fixed-dose combination amlodipine/benazepril versus component-based free-combination therapy
2008
75
Role of vascular inflammation in coronary artery disease: potential of anti-inflammatory drugs in the prevention of atherothrombosis. Inflammation and anti-inflammatory drugs in coronary artery disease
2015
70
Selective BET Protein Inhibition with Apabetalone and Cardiovascular Events: A Pooled Analysis of Trials in Patients with Coronary Artery Disease
2018
70
0
1
2
next
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.